Results of the phase 2 MALE clinical trial comparing 3 treatment regimens in men with hormone-receptor positive breast cancer are reported.
The largest increase in cancer diagnosis at age 65 years was in stage I for all breast cancer, colon cancer, prostate cancer, and lung cancer.
A team of investigators conducted a retrospective study to determine the relationship of intrinsic breast cancer subtypes on survival in patients undergoing endocrine therapy plus ribociclib.
A team of investigators assessed the frequency and timing of unplanned breast implant removal in patients undergoing with mastectomy, reconstruction, and postmastectomy radiation therapy for locally advanced breast cancer.
Results of an assessment of tissue composition changes experienced by breast cancer survivors without lymphedema are presented.
Results from the phase 3 monarchE trial on the addition of abemaciclib to endocrine therapy in patients with early breast cancer were presented at the 17th St. Gillen International Breast Cancer Conference.
A team of investigators sought to evaluate safety, tolerability, and antitumor activity neoadjuvant niraparib for patients with localized breast cancer.
A team of investigators sought to identify the most accurate preoperative breast imaging technique for determining tumor size in individuals with early breast cancer.
A team of researches sought to assess the effectiveness of breast cancer surveillance among patients with BRCA1/2 mutations.
A team of radiologists explain their strategy for maintaining breast cancer screening in women with managing a potential side effect of vaccination.